JPRN-jRCT2080220356未知3 期
Controlled study for Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
ovartis Pharma K.K., ONO Pharmaceutical Co., Ltd.0 个研究点开始时间: 2007年3月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •1.A diagnosis of dementia of the Alzheimer's type according to the DSM-IV criteria
- •2.A clinical diagnosis of probable AD according to NINCDS/ADRDA criteria
- •3.An MMSE score of >= 10 and = 20
- •Exclusion criteria
- •1.A current DSM-IV diagnosis of major depression
- •2.Taken rivastigmine in the past
- •3.A score of > 5 on the Modified Hachinski Ischemic Scale (MHIS)
- •Other protocol-defined inclusion/exclusion criteria may apply
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
Effect of Rivaroxaban in ThrombosisIRCT20231021059793N1Tehran University of Medical Sciences20
已完成
不适用
Investigation on efficacy and safety of rivastigmin patch in patients switched from donepezil with mild to moderate Alzheimer's diseaseJPRN-UMIN000010842Kagawa University School of Medicine100
已完成
不适用
A pilot study to evaluate efficacy and safety of resveratrol for muscular dystrophy.Duchenne muscular dystrophy, Becker muscular dystrophy, Fukuyama congenital muscular dystrophyJPRN-UMIN000014836Sapporo Medical University10
招募中
不适用
Investigation of the safety and effectiveness of irreversible electroporation (IRE) using the NanoKnife® System in patients with unresectable stage 3 pancreatic cancer who have received 3 months of chemotherapy.Cancer - PancreaticPancreatic CancerACTRN12621000955819Walter & Eliza Hall Institute of Medical Research (WEHI)20
已完成
不适用
A randomised placebo-controlled trial of rivastigmine in delirium in older medical in-patients: a pilot studyDeliriumISRCTN27327721South Manchester University Hospitals NHS Trust (UK)50